OREX
Geode Capital Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-59,849
| Closed | -$77K | – | 4153 |
|
|
2017
Q4 | $77K | Sell |
59,849
-4,379
| -7% | -$5.63K | ﹤0.01% | 3870 |
|
|
2017
Q3 | $136K | Hold |
64,228
| – | – | ﹤0.01% | 3757 |
|
|
2017
Q2 | $186K | Sell |
64,228
-1,892
| -3% | -$5.48K | ﹤0.01% | 3710 |
|
|
2017
Q1 | $227K | Buy |
66,120
+258
| +0.4% | +$886 | ﹤0.01% | 3613 |
|
|
2016
Q4 | $114K | Buy |
65,862
+172
| +0.3% | +$298 | ﹤0.01% | 3764 |
|
|
2016
Q3 | $218K | Sell |
65,690
-591,232
| -90% | -$1.96M | ﹤0.01% | 3567 |
|
|
2016
Q2 | $282K | Sell |
656,922
-105,396
| -14% | -$45.2K | ﹤0.01% | 3450 |
|
|
2016
Q1 | $428 | Sell |
762,318
-21,873
| -3% | -$12 | ﹤0.01% | 3312 |
|
|
2015
Q4 | $1.35M | Buy |
784,191
+43,553
| +6% | +$74.8K | ﹤0.01% | 2745 |
|
|
2015
Q3 | $1.56M | Buy |
740,638
+30,339
| +4% | +$64K | ﹤0.01% | 2599 |
|
|
2015
Q2 | $3.52M | Buy |
710,299
+1,104
| +0.2% | +$5.46K | ﹤0.01% | 2143 |
|
|
2015
Q1 | $5.55M | Buy |
709,195
+25,636
| +4% | +$201K | ﹤0.01% | 1801 |
|
|
2014
Q4 | $4.14M | Buy |
683,559
+31,229
| +5% | +$189K | ﹤0.01% | 1925 |
|
|
2014
Q3 | $2.78M | Buy |
652,330
+10,254
| +2% | +$43.7K | ﹤0.01% | 2163 |
|
|
2014
Q2 | $3.97M | Buy |
642,076
+109,134
| +20% | +$674K | ﹤0.01% | 1932 |
|
|
2014
Q1 | $3.46M | Buy |
532,942
+110,322
| +26% | +$717K | ﹤0.01% | 2009 |
|
|
2013
Q4 | $2.38M | Buy |
422,620
+10,700
| +3% | +$60.2K | ﹤0.01% | 2188 |
|
|
2013
Q3 | $2.53M | Buy |
411,920
+47,671
| +13% | +$293K | ﹤0.01% | 2030 |
|
|
2013
Q2 | $2.13M | Buy |
+364,249
| New | +$2.13M | ﹤0.01% | 1994 |
|